Cheap heart drug boosts breast cancer survival
Groundbreaking UK research reveals a cheap, widely available heart drug, propranolol, could significantly improve survival rates for women battling aggressive triple-negative breast cancer, offering new hope for a notoriously difficult-to-treat disease.